Analysing adverse drug reaction patterns observed during district residency program: a prospective observational study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20240986Keywords:
Pharmacovigilance, Causality, ADR, Drug safety, Rural area, Reporting patternAbstract
Background: Adverse drug reactions (ADRs) pose a substantial cost to global healthcare systems. The heterogeneous patient demographics and healthcare environments of district residency programmes (DRPs) provide special possibilities for detecting trends of ADRs. In order recognize recurring trends and related variables, this study will examine ADR incidents that occur during DRPs.
Methods: A prospective observational research with forty-three patients was carried out. Standardized reporting forms were used to gather data on ADRs, and descriptive statistical techniques were used to analyse the results. We evaluated medication information, patient demographics, and ADR features to seek for patterns and potential causes.
Results: Preliminary analysis revealed a diverse range of ADRs observed during DRPs, spanning various severity levels and therapeutic classes. Common ADRs included gastrointestinal disturbances, allergic reactions, and central nervous system effects. Factors such as patient age, polypharmacy, and comorbidities emerged as potential predictors of ADR occurrence.
Conclusions: The panorama of ADRs seen during DRPs is clarified by this study, underscoring the significance of careful monitoring, and reporting mechanisms in these initiatives. Gaining insight into ADR trends and related variables can help in improving patient safety, simplifying drug management plans, and directing future educational initiatives for medical professionals.
Metrics
References
Jose J, Al Rubaie MH, Ramimmy H Al, Varughese SS. Pharmacovigilance basic concepts and an overview of the system in oman. Sultan Qaboos Univ Med J. 2021;21(2):e161-3.
Cutroneo PM, Polimeni G. Adverse Drug Reactions: Definitions, Classifications and Regulatory Aspects. In: Pharmacovigilance in Psychiatry. Springer International Publishing. 2016;9-25.
Khan Z, Karatas Y. Adverse drug reaction reporting for more than a decade: The need for pharmacovigilance policy implementation in Turkey. J Taibah Univ Med Sci. 2022;17:340-2.
Soiza RL. Global pandemic—the true incidence of adverse drug reactions. Age and Ageing. Oxford University Press. 2020;49:934-5.
Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a South Indian hospital - Their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12(8):687-92.
Pattanaik S, Dhamija P, Malhotra S, Sharma N, Pandhi P. Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: A prospective study. Br J Clin Pharmacol. 2009;67(3):363-9.
Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016;81:323-34.
Arulappen AL, Danial M, Sulaiman SAS. Evaluation of reported adverse drug reactions in antibiotic usage: A retrospective study from a tertiary care hospital, Malaysia. Front Pharmacol. 2018;9(8).
Patrick J, McDonnell, Michael R. Hospital Admissions Resulting from Preventable Adverse Drug Reactions. Philadelphia. 2002.
Shukla S, Sharma P, Gupta P, Pandey S, Agrawal R, Rathour D. Current scenario and future prospects of adverse drug reactions (ADRs) monitoring and reporting mechanisms in the rural areas of India. Curr Drug Saf. 2024;19(2):172-90.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45.
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.
Daulat MP, V. J. AA, Singh P, Raj B. A prospective study of adverse drug reactions in a tertiary care teaching hospital. Int J Basic Clin Pharmacol. 2018;7(10):1965.
Kumar DP. Patterns of adverse drug reactions: a study in a tertiary care. Int J Basic Clin Pharmacol. 2019;8(7):1497.
Ramakrishnaiah H, Krishnaiah V, Pundarikaksha H, Ramakrishna V. A prospective study on adverse drug reactions in outpatients and inpatients of medicine department in a tertiary care hospital. Int J Basic Clin Pharmacol. 2015;515-21.
